Oral isotretinoin: the most promising dermatological off-label uses

References

• Gerster H. Vitamin A: functions, dietary requirements and safety in humans. Int. J. Vitam. Nutr. Res.67, 71–90 (1997).
   PubMed Web of Science ®Google Scholar
• Petkovich M, Brand MJ, Krust A et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature330, 444–450 (1987).
   PubMed Web of Science ®Google Scholar
• Brand MJ, Petkovich M, Krust A et al. Identification of a second human retinoic acid receptor. Nature332, 850–853 (1988).
   PubMed Web of Science ®Google Scholar
• Krust A, Kastner P, Petkovich M et al. A third human retinoic acid receptor hRAR-γ. Proc. Natl. Acad. Sci. USA86, 5310–5314 (1989).
   PubMed Web of Science ®Google Scholar
• Ross TC, Jugert FK, Merk HF, Bickers DR. Retinoid metabolism in the skin. Pharm. Rev.50, 315–333 (1998).
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Martin PJ, Flajollet S et al. Transcriptional activities of retinoic acid receptors. Vitam. Horm.70, 199–264 (2005).
   PubMed Web of Science ®Google Scholar
• Stratigos AJ, Katsambas AD. The role of topical retinoids in the treatment of photoaging. Drugs65, 1061–1072 (2005).
   PubMed Web of Science ®Google Scholar
• Kang S. The mechanism of action of topical retinoids. Cutis75(Suppl. 2), 10–13; discussion 13 (2005).
   PubMed Web of Science ®Google Scholar
• Blaner WS. Cellular metabolism and actions of 13-cis-retinoic acid. J. Am. Acad. Dermatol.45, S129–S135 (2001).
   PubMed Web of Science ®Google Scholar
• Orfanus CE, Zouboulis CC. Oral retinoids in the treatment of seborrhea and acne. Dermatology196, 140–147 (1998).
   PubMed Web of Science ®Google Scholar
• Törmä H. Interaction of isotretinoin with endogenous retinoids. J. Am. Acad. Dermatol.45, S143–S149 (2001).
   Google Scholar
• Ingram JR, Grindlay DJ, Williams HC. Management of acne vulgaris: an evidence-based update. Clin. Exp. Dermatol.35, 351–354 (2010).
   PubMed Web of Science ®Google Scholar
• Akyol M, Özçelik S. Non-acne dermatologic indications for systemic isotretinoin. Am. J. Clin. Dermatol.6, 175–184 (2005).
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Nuzzo A et al. Multicenter Phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer. J. Immunother.29, 87–94 (2006).
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Cesta A et al. Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer. Cancer Immunol. Immunother.56, 699–708 (2007).
   PubMed Web of Science ®Google Scholar
• Lens M, Medenica L. Systemic retinoids in chemoprevention of non-melanoma skin cancer. Expert Opin. Pharmacother.9, 1363–1374 (2008).
   PubMed Web of Science ®Google Scholar
• Jugeau S, Tenaud I, Knol AC et al. Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol.153, 1105–1113 (2005).
   PubMed Web of Science ®Google Scholar
• Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear, factor-κ and activator protein-1 in inflammatory acne lesions in vivo. Am. J. Pathol.166, 1691–1699 (2005).
   PubMed Web of Science ®Google Scholar
• Kurokawa I, Danby FW, Ju Q et al. New developments in our understanding of acne pathogenesis and treatment. Exp. Dermatol.18, 821–832 (2009).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Bohm M. Neuroendocrine regulation of sebocytes – a pathogenic link between stress and acne. Exp. Dermatol.13(Suppl.), 31–35 (2008).
   Google Scholar
• Sampaio SAP, Bagatin E. Experience in 65 years treating acne and 26 years with oral isotretinoin. An. Bras. Dermatol.83, 247–259 (2008).
   Web of Science ®Google Scholar
• Strauss JS, Krowchuk DP, Leyden JJ. Guidelines of care for acne vulgaris management. J. Am. Acad. Dermatol.56, 651–663 (2007).
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Gollnick H. New insights into management of acne: an update from the Global Alliance to improve outcomes in acne group. J. Am. Acad. Dermatol.60, S1–S50 (2009).
   PubMed Web of Science ®Google Scholar
• Verros CD. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris? J. Eur. Acad. Dermatol. Venereol.21, 1270–1271 (2007).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Retinoids – which dermatological indications will benefit in the near future. Skin Pharmacol. Appl. Skin Physiol.14, 303–315 (2004).
   Google Scholar
• Strauss JS, Stranieri AM. Changes in long-term sebum production from isotretinoin therapy. J. Am. Acad. Dermatol.6, 751–756 (1982).
   PubMed Web of Science ®Google Scholar
• Geissler SE, Michelsen S, Plewig G. Very low dose isotretinoin is effective in controlling seborrhea. J. Dtsch. Dermatol. Ges.1, 952–958 (2001).
   Google Scholar
• Hernandez-Perez E, Khawaja HA, Alvarez TYM. Oral isotretinoin as part of the treatment of cutaneous aging. Dermatol. Surg.26(7), 649–652 (2000).
   PubMed Web of Science ®Google Scholar
• Kalil CL, Fachinello FZ, Lamb FM, Comunello LN. Use of oral isotretinoin in photoaging therapy. Skinmed7(1), 10–14 (2008).
   PubMedGoogle Scholar
• Rabello-Fonseca RM, Azulay DR, Mandarim-de-Lacerda CA, Cuzzi T, Manela-Azulay M. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. J. Eur. Acad. Dermatol. Venereol.23, 115–123 (2009).
   PubMed Web of Science ®Google Scholar
• Bagatin E, Parada MOB, Miot HA et al. A randomized and controlled trial about the use of oral isotretinoin for photoaging. Int. J. Dermatol.49, 207–214 (2010).
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Xhauflaire-Uhoda E, Piérard GE. Revisiting dandruff. Int. J. Cosmet. Sci.28, 311–318 (2006).
   PubMedGoogle Scholar
• Grimalt R. A practical guide to scalp disorders. J. Investig. Dermatol. Symp. Proc.12, 10–14 (2007).
   PubMedGoogle Scholar
• Bailey P, Arrowsmith C, Darling K et al. A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO on the scalp vs. antidandruff efficacy and antimycotic activity. Int. J. Cosmet. Sci.25, 183–188 (2003).
   PubMedGoogle Scholar
• Segot-Chicq E, Compan-Zaouati D, Wolkenstein P et al. Development and validation of a questionnaire to evaluate how a cosmetic product for oily skin is able to improve well-being in women. J. Eur. Acad. Deratol. Venereol.21, 1181–1186 (2007).
   PubMed Web of Science ®Google Scholar
• Zoubolis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J. Invest. Dermatol.126, 2154–2156 (2003).
   Google Scholar
• Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am. Fam. Physician74, 125–130 (2006).
   PubMed Web of Science ®Google Scholar
• DeAngelis YM, Gemmer CM, Kaczvinsky JR et al. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J. Investig. Dermatol. Symp. Proc.10, 295–297 (2005).
   PubMedGoogle Scholar
• Waldroup W, Scheinfeld N. Medicated shampoos for the treatment of seborrheic dermatitis. J. Drugs Dermatol.7, 699–703 (2008).
   PubMed Web of Science ®Google Scholar
• Reygagne P, Poncet M, Sidou F, Soto P. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis79, 397–403 (2007).
   PubMed Web of Science ®Google Scholar
• Borgers M, Degreef H. The role of ketoconazole in seborrheic dermatitis. Cutis80, 359–363 (2007).
   PubMed Web of Science ®Google Scholar
• Gupta AK, Nicol KA. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. Int. J. Dermatol.45, 66–69 (2006).
   PubMed Web of Science ®Google Scholar
• Warshaw EM, Wohlhuter RJ, Liu A et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J. Am. Acad. Dermatol.57, 257–264 (2007).
   PubMed Web of Science ®Google Scholar
• Rallis E, Korfitis C, Gregoriou S, Rigopoulos D. Assigning new roles to topical tacrolimus. Expert Opin. Investig. Drugs16, 1267–1276 (2007).
   PubMed Web of Science ®Google Scholar
• Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am. J. Clin. Dermatol.8, 235–238 (2007).
   PubMed Web of Science ®Google Scholar
• Vena GA, Micali G, Santoianni P et al. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int. J. Immunopathol. Pharmacol.18, 745–753 (2005).
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Reich A, Wesolowska- Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses52, 357–363 (2008).
   PubMed Web of Science ®Google Scholar
• McAleer MA, Lacey N, Powell FC. The pathophysiology of rosacea. G. Ital. Dermatol. Venereol.144, 663–671 (2009).
   PubMed Web of Science ®Google Scholar
• Scheinfeld N, Berk T. A review of the diagnosis and treatment of rosacea. Postgrad. Med.122, 139–143 (2010).
   PubMed Web of Science ®Google Scholar
• van ZuurenEJ, Gupta AK, Gover MD et al. Systematic review of rosacea treatments. J. Am. Acad. Dermatol.56, 107–115 (2007).
   PubMed Web of Science ®Google Scholar
• Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J. Eur. Acad. Dermatol. Venereol.19, 273–285 (2005).
   PubMed Web of Science ®Google Scholar
• Del RossoJQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis80, 113–120 (2007).
   PubMed Web of Science ®Google Scholar
• Kennedy Carney C, Cantrell W, Elewski BE. Rosacea: a review of current topical, systemic and light-based therapies. G. Ital. Dermatol. Venereol.144, 673–688 (2009).
   PubMed Web of Science ®Google Scholar
• Del RossoJQ, Leyden JJ, Thiboutot D, Webster GF. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis82, 5–12 (2008).
   PubMed Web of Science ®Google Scholar
• Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J. Drugs Dermatol.6, 495–498 (2007).
   PubMedGoogle Scholar
• Butterwick KJ, Butterwick LS, Han A. Laser and light therapies for acne rosacea. J. Drugs Dermatol.5, 35–39 (2006).
   PubMedGoogle Scholar
• Plewig G, Nikolowski J, Woll HH. Action of isotretinoin in acne rosacea and gram-negative folliculitis. J. Am. Acad. Dermatol.6, 766–785 (1982).
   PubMed Web of Science ®Google Scholar
• Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int. J. Dermatol.25, 660–663 (1986).
   PubMed Web of Science ®Google Scholar
• Turjanmaa K, Reunala T. Isotretinoin treatment of rosacea. Acta Dermatol. Venereol.67, 89–91 (1987).
   PubMed Web of Science ®Google Scholar
• Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch. Dermatol.130, 319–324 (1994).
   PubMedGoogle Scholar
• Gollnick H, Blume-Peytavi U, Szabó EL et al. Systemic isotretinoin in the treatment of rosacea – doxycycline- and placebo-controlled, randomized clinical study. J. Dtsch Dermatol. Ges.8(7), 505–515 (2010).
   PubMed Web of Science ®Google Scholar
• Campbell RM, DiGiovanna JJ. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients. Dermatol. Ther.19, 306–314 (2006).
   PubMed Web of Science ®Google Scholar
• Nijstein TE, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J. Am. Acad. Dermatol.49, 644–650 (2003).
   PubMed Web of Science ®Google Scholar
• Marquez C, Bair SM, Smithberger E et al. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. J. Drugs Dermatol.9, 753–758 (2010).
   PubMed Web of Science ®Google Scholar
• Harwood CA, Leedham-Green M, Leigh IM, Proby MC. Low-dose retinoids in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients: a 16-year retrospective study. Arch. Dermatol.141, 456–464 (2005).
   PubMedGoogle Scholar
• Bukhari MH, Qureshi SS, Niazi S et al. Chemotherapeutic/chemopreventive role of retinoids in chemically induced skin carcinogenesis in albino mice. Int. J. Dermatol.46, 1160–1165 (2007).
   PubMed Web of Science ®Google Scholar
• Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J. Am. Acad. Dermatol.21, 144–145 (1989).
   PubMed Web of Science ®Google Scholar
• Bellman BA, Eaglstein WH, Miller J. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. Transplantation61, 173 (1996).
   PubMed Web of Science ®Google Scholar
• Anolik JH, Di Giovanna JJ, Gaspari AA. Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum. Br. J. Dermatol.138, 236–241 (1998).
   PubMed Web of Science ®Google Scholar
• Levine N, Moon TE, Cartmel B et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol. Biomarkers Prev.6, 957–961 (1997).
   PubMed Web of Science ®Google Scholar
• Bath-Hextall F, Leonardi-Bee J, Somchand N, Webster A, Delitt J, Perkins W. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst. Rev. (4), CD005414 (2007).
   Google Scholar
• Makrantonaki E, Zouboulis CC. Molecular mechanisms of skin aging: state of the art. Ann. NY Acad. Sci.1119, 40–50 (2007).
   PubMed Web of Science ®Google Scholar
• Makrantonaki E, Zouboulis CC. William J Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology214, 352–360 (2007).
   PubMed Web of Science ®Google Scholar
• Fisher GJ, Kang S, Varani J et al. Mechanisms of photoaging and chronological skin aging. Arch. Dermatol.138, 1462–1470 (2002).
   PubMed Web of Science ®Google Scholar
• Rabe JH, Mamelak AJ, McElgunn PJS, Morison WL, Sauder DN. Photoaging: mechanisms and repair. J. Am. Acad. Dermatol.55, 1–19 (2006).
   PubMed Web of Science ®Google Scholar
• Pillai S, Oresajo C, Hayward J. Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation – a review. Int. J. Cosmet. Sci.27, 17–34 (2005).
   PubMedGoogle Scholar
• Makrantonaki E, Zouboulis CC. Dermatoendocrinology. Skin aging. Hautarzt61, 505–510 (2010).
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Date A, Patravale V et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin. Interv. Aging1(4), 327–348 (2006).
   PubMed Web of Science ®Google Scholar
• Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence based analysis. J. Am. Acad. Dermatol.39, S55–S61 (1998).
   PubMed Web of Science ®Google Scholar
• Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J. Am. Acad. Dermatol.15, 836–859 (1986).
   PubMed Web of Science ®Google Scholar
• Maddin S, Lauharanta J, Agache P, Burrows L, Zultak M, Bulger L. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J. Am. Acad. Dermatol.42, 56–63 (2000).
   PubMed Web of Science ®Google Scholar
• Kafi R, Kwak HS, Schumacher WE et al. Improvement of naturally aged skin with vitamin A (retinol). Arch. Dermatol.143, 606–612 (2007).
   PubMedGoogle Scholar
• Ellis CH, Krach KJ. Uses and complications of isotretinoin therapy. J. Am. Acad. Dermatol.45, S150–S157 (2001).
   PubMed Web of Science ®Google Scholar
• Goldsmith LA, Bolognia JL, Callen JP et al. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J. Am. Acad. Dermatol.50, 900–906 (2004).
   PubMed Web of Science ®Google Scholar
• De Marchi MA, Maranhão RC, Brandizzi LI, Souza DR. Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne. Arch. Dermatol. Res.297, 403–408 (2006).
   PubMed Web of Science ®Google Scholar
• Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology204, 232–235 (2002).
   PubMed Web of Science ®Google Scholar
• Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch. Dermatol.142, 1055–1057 (2006).
   PubMedGoogle Scholar
• Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne. J. Eur. Acad. Dermatol. Venereol.20, 773–776 (2006).
   PubMed Web of Science ®Google Scholar
• Scheinfeld N. Schools of pharmacology: retinoid update. J. Drugs Dermatol.5, 921–922 (2006).
   PubMedGoogle Scholar
• Bérard A, Azoulay L, Koren G et al. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br. J. Clin. Pharmacol.63, 196–205 (2007).
   PubMed Web of Science ®Google Scholar
• Sladden MJ, Harman KE. What is the chance of a normal pregnancy in a woman whose fetus has been exposed to isotretinoin? Arch. Dermatol.143, 1187–1188 (2007).
   PubMed Web of Science ®Google Scholar
• Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch. Dermatol.136, 1231–1236 (2000).
   PubMedGoogle Scholar
• Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br. J. Dermatol.140, 273–282 (1999).
   PubMed Web of Science ®Google Scholar
• Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin. Cutan. Med. Surg.26, 210–220 (2007).
   PubMed Web of Science ®Google Scholar
• Bigby M. Does isotretinoin increase the risk of depression? Arch. Dermatol.144, 1197–1199 (2008).
   PubMedGoogle Scholar
• Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression. Can. J. Clin. Pharmacol.14, 227–233 (2007).
   PubMedGoogle Scholar
• Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case–control study. Am. J. Gastroenterol.104, 2774–2778 (2009).
   PubMed Web of Science ®Google Scholar
• Crockett SD, Gulati A, Sandler RS, Kappelman MD. A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am. J. Gastroenterol.104, 2387–2393 (2009).
   PubMed Web of Science ®Google Scholar
• Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am. J. Gastroenterol. doi: 10.1038/ajg.2010.303 (2010) (Epub ahead of print).
   Google Scholar
• Rubenstein R, Roenigk H, Stegman SJ et al. Atypical keloids after dermabrasion of patients taking isotretinoin. J. Am. Acad. Dermatol.15, 280–285 (1986).
   PubMed Web of Science ®Google Scholar
• Zachariae H. Delayed wound healing and keloid formation following argon laser treatment dermabrasion during isotretinoin treatment. Br. J. Dermatol.118, 703–706 (2010).
   Google Scholar
• Ginarte M, Peteiro C, Toribio J. Keloid formation induced by isotretinoin therapy. Int. J. Dermatol.38, 228–229 (1999).
   PubMed Web of Science ®Google Scholar
• Roenigk HH, Pinski JB, Robinson JK. Acne, retinoids, and dermabrasion. J. Dermatol. Surg. Oncol.11, 396–398 (1985).
   PubMedGoogle Scholar
• Khatri KA. Diode laser hair removal in patients undergoing isotretinoin therapy. Dermatol. Surg.30, 1205–1207 (2004).
   PubMed Web of Science ®Google Scholar
• Tan SR, Tope WD. Effect of acitretin on wound healing in organ transplant recipients. Dermatol. Surg.30, 667–673 (2004).
   PubMed Web of Science ®Google Scholar
• Abdelmalek M, Spencer J. Retinoids and wound healing. Dermatol. Surg.32, 1219–1230 (2006).
   PubMed Web of Science ®Google Scholar
• Bagatin E, dos Santos Guadanhim LR, Yarak S, Kamamoto CS, de Almeida FA. Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol. Surg.36, 483–489 (2010).
   PubMed Web of Science ®Google Scholar
• Rivera AE. Acne scarring: a review and current treatment modalities. J. Am. Acad. Dermatol.59, 659–676 (2008).
   PubMed Web of Science ®Google Scholar